PARTI Background Vireo GrowthInc. is a reporting issuer in Canada, with its securities listed for trading on the Canadian Securities Exchange (the CSE ) under the symbol VREO and on the OTCQX under the symbol VREOF. Vireo Growth is a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst ...
Q2 FY2026 — expected 2026-08-11
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | VREOF | discussed_in_filing Cybersecurity | |
| topic_mention | VREOF | discussed_in_filing Trusted Computing | |
| topic_mention | VREOF | discussed_in_filing Blockchain & Crypto | |
| topic_mention | VREOF | discussed_in_filing Supply Chain | |
| topic_mention | VREOF | discussed_in_filing Regulation | |
| topic_mention | VREOF | discussed_in_filing Automotive | |
| topic_mention | VREOF | discussed_in_filing Healthcare & Bio | |
| topic_mention | VREOF | discussed_in_filing Platform & Ecosystem | |
| topic_mention | VREOF | discussed_in_filing Cybersecurity | |
| topic_mention | VREOF | discussed_in_filing Trusted Computing | |
| topic_mention | VREOF | discussed_in_filing Blockchain & Crypto | |
| topic_mention | VREOF | discussed_in_filing Supply Chain | |
| topic_mention | VREOF | discussed_in_filing Regulation | |
| topic_mention | VREOF | discussed_in_filing Automotive | |
| topic_mention | VREOF | discussed_in_filing Healthcare & Bio | |
| topic_mention | VREOF | discussed_in_filing Platform & Ecosystem | |
| topic_mention | VREOF | discussed_in_filing Cybersecurity | |
| topic_mention | VREOF | discussed_in_filing Trusted Computing | |
| topic_mention | VREOF | discussed_in_filing Blockchain & Crypto | |
| topic_mention | VREOF | discussed_in_filing Supply Chain |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2025-12-31 | 0001104659-26-029561 | EDGAR | 101K words |
| 2025-03-04 | 2024-12-31 | 0001558370-25-002130 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001558370-24-004519 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001558370-23-005294 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0001558370-22-003583 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001104659-21-044840 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001104659-25-110364 | EDGAR | 28K words |
| 2025-08-13 | 2025-06-30 | 0001558370-25-011401 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001558370-25-007072 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001558370-24-015533 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001558370-24-011109 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001544784-24-000027 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001558370-23-019027 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001558370-23-014893 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001558370-23-009838 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017776 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013196 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001558370-22-008247 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-06 | 0001104659-26-039924 | EDGAR | 5K words |
| 2026-03-30 | 0001104659-26-036876 | EDGAR | — |
| 2026-03-25 | 0001104659-26-034509 | EDGAR | — |
| 2026-03-17 | 0001104659-26-028946 | EDGAR | — |
| 2025-12-30 | 0001104659-25-125248 | EDGAR | — |
| 2025-12-29 | 0001104659-25-124843 | EDGAR | — |
| 2025-12-22 | 0001104659-25-123459 | EDGAR | — |
| 2025-12-10 | 0001104659-25-119847 | EDGAR | — |
| 2025-11-12 | 0001104659-25-109800 | EDGAR | — |
| 2025-11-03 | 0001104659-25-105541 | EDGAR | — |
108 total filings indexed. 80 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001771706 |
| Ticker | VREOF |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | A1 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report